- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02201498
Randomized Clinical Trial for Primary Molar Pulpotomy, Biodentine Vs Formocresol-ZOE
January 10, 2018 updated by: Université de Montréal
A New Technique for Primary Molar Pulpotomy : A Randomized Clinical Trial Comparing the Radiographic and Clinical Success of the Formocresol-zinc Oxide Eugenol Technique and the Biodentine Technique
This is a RCT that will compare the clinical and radiographic success of pulpotomies on primary molars between the traditional technique (Formocresol/ZOE) and the new technique with Biodentine.
180 pulpotomies (90 in each group) will be followed for a period of 12 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3T1C5
- CHU Sainte-Justine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 10 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ASA I and II
- less than 1/3 of physiologic root resorption
- asymptomatic tooth (with no history of symptoms)
- no clinical or radiological sign of pathology
- vital tooth, with carious pulpal exposure
- hemostasis must be obtained simply with pressure in less than 5 min
- teeth restored with stainless steel crowns
Exclusion Criteria:
- more than 10 y.o.
- symptomatic tooth (presently or history of symptoms)
- previous pulpal treatment on the tooth
- necrotic pulp
- hyperemic pulp
- inadequate operative technique, defective restauration
- non diagnostic x-ray (pre or post treatment)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Formocresol/OZE
Conventional pulpotomy technique, with formocresol and zinc oxide eugenol
|
|
|
ACTIVE_COMPARATOR: Biodentine
New technique, with biodentine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
clinical success
Time Frame: 12 months post treatment
|
12 months post treatment
|
|
radiographic success
Time Frame: 12 months post treatment
|
12 months post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (ACTUAL)
June 1, 2016
Study Completion (ACTUAL)
June 1, 2016
Study Registration Dates
First Submitted
July 24, 2014
First Submitted That Met QC Criteria
July 24, 2014
First Posted (ESTIMATE)
July 28, 2014
Study Record Updates
Last Update Posted (ACTUAL)
January 12, 2018
Last Update Submitted That Met QC Criteria
January 10, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BIODENT1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Dental Caries
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Cairo UniversityNot yet recruitingPulpitis | Dental Pulp Diseases | Deep Caries Lesion of Primary Teeth | Decayed Teeth | Reversible Pulpitis | Deep Proximal Caries | Deep Occlusal Caries
-
Rawda Hesham Abd ElAzizActive, not recruitingDeep Caries | Caries,DentalEgypt
-
Firat UniversityCompletedDeep Dental CariesTurkey (Türkiye)
-
University of Illinois at ChicagoCompleted
-
Cairo UniversityNot yet recruiting
-
burcu gözeticiIstanbul Medipol University HospitalCompletedDental Caries | Deep Caries | Pulp Exposure, DentalTurkey
-
Cukurova UniversityRecruitingPulp Exposure, Dental | Deep Dental CariesTurkey (Türkiye)
-
Cairo UniversityActive, not recruitingDeep Caries | Pulp Exposure, DentalEgypt
-
Cairo UniversityNot yet recruitingEvaluation of Bioactive Giomer Material Versus Nanohybrid Resin Composite in Deep Marginal ElevationDental Caries | Deep Caries
Clinical Trials on Pulpotomies with Formocresol/OZE and Biodentine
-
Hadassah Medical OrganizationWithdrawnPulpotomy | Tooth, Deciduous
-
McGill University Health Centre/Research Institute...Not yet recruitingPulp Disease, Dental
-
Cairo UniversityCompleted
-
Semmelweis UniversityRecruitingPulpitis | Irreversible Pulpitis | Pulp Disease, Dental | Reversible Pulpitis | Dental Caries Extending to PulpHungary
-
Charite University, Berlin, Germany3M; SeptodontNot yet recruitingIrreversible Pulpitis | Dentine Caries | Reversible Pulpitis
-
HITEC-Institute of Medical SciencesCompletedSymptomatic Irreversible PulpitisPakistan
-
Mansoura UniversityActive, not recruiting
-
Saglik Bilimleri UniversitesiCompletedIndirect Pulp Capping | Dentin, CariousTurkey
-
José Arturo Garrocho RangelUnknown